HeroinTimes   Turn Page
 | content | editorial | letters | news | viewpoint | medical | features | law | flashback |
 | fiction | street | detox | people | obituary | w-watch | i-vention | pharmacy | pro-shop |
 | hep-c | women | spiritual | treatment | exchange | memo-park | archives | about-us |
 


Our Favorite Comix. It will "draw" you into Recovery

Steroid Users are Big Needle-Exchange Clients
The latest report on the needle-exchange program in Ontario, Canada found that the majority of people using the program were steroid users, not heroin addicts.
According to the report by the Ontario Health and Social Services Committee, 9,320 needles were handed out and 6,899 were collected during the first year of the program.

Of those utilizing the program, 65 percent were steroid users and the remaining 35 percent were intravenous users of such drugs as crack cocaine and heroin.
In addition, the report found that 202 clients used the needle-exchange program's other services, including drug counseling and informational pamphlets on safe drug injection and sexually transmitted disease prevention.
"We are very pleased with how well the program is doing," said Cate Bannan, manager of AIDS, sexually transmitted diseases, sexual health and needle-exchange services for the public-health department. |||
White House Questions Ability of DEA

A White House assessment of the Drug Enforcement Administration (DEA) criticizes the agency for being "unable to demonstrate progress in reducing the availability of illegal drugs in the United States."
The assessment by the White House Office of Management and Budget, which was released as part of the administration's budget plan, says the DEA lacks clear long-term strategies and goals, does not hold managers accountable for problems, and has financial controls that do not comply with federal standards.

The assessment recommends only a 1 percent increase in the DEA budget, to $1.56 billion, the smallest increase in 15 years. DEA officials said they are addressing the issues raised in the report.
Critics of the DEA said the report's findings are long overdue. "Typically, the DEA has gotten a pretty free ride," said Ethan Nadelmann, executive director of the New York-based Drug Policy Alliance. "Nobody was really held to account for the issue of reducing overall drug use. But this suggests some measure of seriousness about actually putting in a set of real criteria."



Ibogaine Dossier

 

N

E

W

S

     
March 2003   turn